SIENNA BIOPHARMACEUTICALS INC (SNNA) Stock Price, Forecast & Analysis
USA - NASDAQ:SNNA -
SNNA Key Statistics, Chart & Performance
The current stock price of SNNA is 0.1358 null. In the past month the price decreased by -35.33%. In the past year, price decreased by -95.04%.
SNNA Latest News, Press Relases and Analysis
About SNNA
Company Profile
Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake Village, United States.
Company Info
SIENNA BIOPHARMACEUTICALS INC
30699 Russell Ranch Road Suite 140
Westlake Village CA 91362
CEO: Frederick C. Beddingfield III
Phone: 818-629-2256
SIENNA BIOPHARMACEUTICALS INC / SNNA FAQ
Can you describe the business of SIENNA BIOPHARMACEUTICALS INC?
Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake Village, United States.
What is the stock price of SIENNA BIOPHARMACEUTICALS INC today?
The current stock price of SNNA is 0.1358 null. The price increased by 34.46% in the last trading session.
Does SNNA stock pay dividends?
SNNA does not pay a dividend.
What is the ChartMill technical and fundamental rating of SNNA stock?
SNNA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of SIENNA BIOPHARMACEUTICALS INC (SNNA) based on its PE ratio?
SIENNA BIOPHARMACEUTICALS INC (SNNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).
Can you provide the market cap for SIENNA BIOPHARMACEUTICALS INC?
SIENNA BIOPHARMACEUTICALS INC (SNNA) has a market capitalization of 4.20M null. This makes SNNA a Nano Cap stock.
SNNA Technical Analysis
SNNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SNNA. SNNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SNNA Financial Highlights
Over the last trailing twelve months SNNA reported a non-GAAP Earnings per Share(EPS) of -2.0300000000000002. The EPS increased by 37.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -110.25% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |